Bellevue Asset Management (Switzerland)’s Amgen AMGN Stock Holding History

Bellevue Asset Management (Switzerland)’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$20M	Buy	123,000 +3,000	+3%	+$472K	3.04%	4
2015 Q3	$16.6M	Buy	120,000 +23,134	+24%	+$3.65M	2.71%	7
2015 Q2	$14.9M	Sell	96,866 -13,000	-12%	-$2.08M	2.06%	11
2015 Q1	$17.6M	Buy	+109,866	New	+$17.3M	2.45%	7

Other funds holding AMGN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s AMGN Position: Q4 2015 in Review

Bellevue Asset Management (Switzerland) increased its Amgen (AMGN) stake by 2.5% in Q4 2015, buying an estimated $472K and bringing the position to 123,000 shares worth $20M. The position accounts for 3.04% of the portfolio, ranked #4.

Bellevue Asset Management (Switzerland) first reported a position in AMGN in Q1 2015 and has held it in 4 quarters since. 1,454 funds tracked by Wall St. Rank hold AMGN as of Q4 2015.

Bellevue Asset Management (Switzerland) held 123,000 shares of Amgen worth $20M as of Q4 2015.
Bellevue Asset Management (Switzerland) bought 3,000 Amgen shares in Q4 2015, an estimated $472K.
Amgen made up 3.04% of Bellevue Asset Management (Switzerland)'s portfolio in Q4 2015, its #4 holding.
Bellevue Asset Management (Switzerland) first reported a position in Amgen in Q1 2015 and has held it in 4 quarters since.
1,454 funds tracked by Wall St. Rank held Amgen as of Q4 2015.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.